Raleigh-based CRO Receives Award for Fourth Consecutive Time

Raleigh, NC, Nov. 10, 2008 - INC Research, a therapeutically-focused contract research organization (CRO) with a trusted process for delivering reliable results, was recognized as the 3rd fastest growing company in the Triangle area by the Triangle Business Journal. The company was recognized at the Fast 50 Awards ceremony on Nov. 6, 2008 at the new Raleigh Convention Center. 

"The investments we've made in our people and our Trusted Process have enabled us to sustain growth in this competitive environment," said James T. Ogle, CEO of INC Research. "We've extended our global reach and therapeutic focus to align our services with customer demand. We are very honored to be recognized by our community for the fourth year in a row."

Recently INC Research launched the Women's Health Division to address the challenges and nuances related to female health conditions, and appointed the head of its Metabolic & Endocrine Diseases practice tin response to the increase of more prevalent metabolic disorders, such as diabetes and obesity. The CRO, which currently has 25 locations in 32 countries, has also increased its presence in emerging regions including India and Latin America.

The Fast 50 award rankings were determined by PricewaterhouseCoopers LLP, who evaluated locally headquartered private companies based on a formula that takes into account both dollar growth and percentage rate of growth over a three-year period. 

About INC Research®
INC Research is a therapeutically-focused contract research organization with an unrivaled reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in therapeutic areas of specialty, and in innovative pediatric trials. The company's Trusted Process™ methodology and therapeutic foresight leads customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, North Carolina, and now in 25 locations in 32 countries worldwide. For more information please visit www.incresearch.com.